You are spot on Dave and the way Her-Vaxx is being trialed and marketed is the guide line for what we can expect with all the other vaxx still to come. IMU is on its way to become a worldwide Immunotherapy powerhouse regardless of what the big guys do with the sp. If, for example, Her-Vaxx would be sold for $ 2b, then it won't matter if the sp was 20c, 28c or 30c the day before.
IMU and big pharma determine any financial amount - not the ASX market manipulators.
GLTA
Ann: HER-Vaxx Immunotherapy Patent Granted in Europe, page-54
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $353.3M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.5¢ | $376.2K | 8.082M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1004677 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 1040062 | 13 |
View Market Depth
| Last trade - 11.15am 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |